Sun Pharmaceutical Industries share price almost unchanged at ₹1,760.00

Key Takeaways:

• Sun Pharmaceutical Industries closed at ₹1,760.00, ₹4.00 above its opening quotation of ₹1,756, compared with a separately quoted daily change of +0.01%. 
• Sun Pharmaceutical Industries's ₹1,760.00 finish was ₹4.00 below the daily midpoint of ₹1,764.00, calculated from a session low of ₹1,751 and high of ₹1,777. 
• Six-month performance of +2.65% differed from Sun Pharmaceutical Industries's annual return of +7.87% by 5.22 percentage points, while the one-month figure was -6.68%. 

Sun Pharmaceutical Industries share price finished almost flat on 9 October 2026 at ₹1,760.00. The quoted gain was just ₹0.2, or 0.01%, against a rounded previous close of ₹1,760. The stock opened lower at ₹1,756, so its open-to-close increase was larger at ₹4.00. The day high was ₹1,777, and the low was ₹1,751, creating a ₹26.00 range. The small session-on-session change consequently differed from both the rise measured from the open and the wider span of prices recorded during the day. 

The closing quotation stood ₹9.00 above the low and ₹17.00 below the high. The midpoint was ₹1,764.00, placing the final price ₹4.00 below it. Sun Pharma ended in the lower half of the band, with the low nearer than the high. The opening quotation was also below the midpoint and below the close. Both the low and high lay outside the opening-to-closing interval. The positive final change was only a small fraction of the full daily range. The stock did not finish at either endpoint, and its final value matched the previous-close field only at that field's rounded precision. 

The historical return record was mixed. One-month performance was -6.68%, and the three-month reading was -6.79%, with the two declines close in size. Six-month performance was positive at +2.65%, while the one-year return was +7.87%. The annual gain exceeded the six-month figure by 5.22 percentage points. The annual range ran from ₹1,584 to ₹2,047, spanning ₹463.00. The close was ₹176.00 above the low and ₹287.00 below the high, placing it nearer the lower annual endpoint. That position differed from the positive signs of both longer-period return figures. The 50-day and 100-day averages were just ₹4.50 apart, considerably less than the day's ₹26.00 range, while both remained above the closing quotation. 

Trading volume reached 1,419,623 shares. Market capitalisation stood at ₹422,283 crore. The 50-day DMA was ₹1,865.40, leaving the finish ₹105.40 below it. The 100-day DMA stood at ₹1,860.90, with a ₹100.90 below comparison. The 200-day reference was lower at ₹1,824.40, placing the closing quotation ₹64.40 below that value. The two shorter averages were near each other and above the longest reference. All three exceeded the close. October 9 ended with an almost unchanged daily result, a modest increase from the open, positive six-month and annual returns, negative monthly and three-month performance, and a closing price beneath every reported moving average.